Jens Eckstein

Jens Eckstein currently serves as a Member of the Board of Directors at Vandria SA and holds the position of Investment Partner at the Hevolution Foundation since July 2023. Since June 2019, Jens has been a Member of the Board of Advisors and Managing Partner at Apollo Health Ventures, focusing on interventions to extend healthy human lifespan. Additionally, Jens has held various roles including President and Member of the Board of Directors at Galilei Biosciences, Chairman and Advisor at Booster Therapeutics and Refoxy Pharma, and Advisor at Thymofox. Jens has also been involved with bosWell as an Angel Investor and Member of the Board of Directors and has been a Kauffman Fellow since 2005. Previously, Jens served as a Non-Executive Director at Imugene Limited from May 2019 to November 2024. Educational background includes a Postdoctoral Fellowship at the University of California, San Francisco, a Ph.D. in Biological Chemistry from the University of Konstanz, and additional studies at Harvard University and the University of Konstanz.